Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
09/2004
09/14/2004US6790978 Thyromimetic organic compounds
09/14/2004CA2264549C Spirocyclic dopamine receptor subtype ligands
09/10/2004WO2004076434A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004076433A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004076402A1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments
09/10/2004WO2004076388A2 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
09/10/2004WO2004075894A1 Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
09/10/2004WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators
09/10/2004WO2004052837A3 Amino substituted hydroxyphenyl benzophenone derivatives
09/10/2004WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives
09/10/2004WO2004009034A3 Thiomolybdate analogues and uses thereof
09/10/2004WO2003079984A3 Substituted tetracycline compounds
09/10/2004CA2516626A1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments
09/10/2004CA2515801A1 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
09/10/2004CA2512663A1 Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176443 Capsaicin receptor ligands
09/09/2004US20040176386 Compounds
09/09/2004US20040176384 inhibit Tissue factor expression and vascular permeability factor expression in cancer cells and in vascular endothelial cells in the tumor microenvironment; low toxicity to normal vascular endothelial cells
09/09/2004US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants
09/09/2004US20040176356 4-(Hydroxyalkyl-)-piperazinyl(thio)acetamide derivatives for treatment of cardiovascular disorders; antiarrhythmia agents; intermittent claudication, angina, congestive heart failure and myocardial infarction
09/09/2004US20040176253 Herbicides; broad active spectrum; on soil and above ground plant parts use
09/09/2004US20040175314 may be incorporated into packaging materials , for example, food and beverage packaging to scavenge unwanted oxygen; to reveal leaks in packages or to indicate package damage caused by handling or tampering
09/09/2004DE10308352A1 Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Arylcycloalkylderivate with branched side chains, to processes for their preparation and their use as medicaments
09/08/2004EP1453841A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them
09/08/2004EP1453816A2 Phenoxy amine compounds and compositions for delivering active agents
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
09/08/2004EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
09/08/2004EP1289972B1 Serine protease inhibitors
09/08/2004EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
09/08/2004EP0944581A4 Process of preparing substituted acrylamides
09/08/2004CN1527823A Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
09/08/2004CN1527820A 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders
09/08/2004CN1527812A New derivatives of substituted anilines with herbicidal activity
09/08/2004CN1165522C Bradykinin receptor antagonists
09/08/2004CN1165308C Compositions and method for reducing respiratory depression and attendant side effect of mu opioid compounds
09/07/2004US6787653 Reacting, in the presence of a metal catalyst, a halogenobenzoic acid derivative with benzene derivative to produce biphenyldicarboxylic acid amide derivative
09/07/2004US6787569 Therapeutic guanidines
09/07/2004US6787522 Antibacterial agents
09/07/2004CA2093770C Aspartic acid derivatives, their preparation and use
09/02/2004WO2004074256A1 Tetrahydroisoquinolinyl sulfamic acids
09/02/2004WO2004074238A1 Phenethylamino sulfamic acids
09/02/2004WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/02/2004WO2004073619A2 Ccr8 antagonists
09/02/2004WO2004056319A3 Substituted n-phenyl sulfonamide bradykinin antagonists
09/02/2004WO2004050647A3 Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
09/02/2004WO2004041256A3 Safe chemical uncouplers for the treatment of obesity
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171845 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
09/02/2004US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS
09/02/2004US20040171839 Serine protease inhibitor; therapy for thrombosis , cardiovascular disorders
09/02/2004US20040171833 Ligands for metals and improved metal-catalyzed processes based thereon
09/02/2004US20040171655 Active against cancer proliferation, growth, and metastasis; such as 3,4,5-trimethoxy-n-(2-methyl-3-phenyl-allyl)-n-[2-(1-methyl-pyrrolidin-2-yl)-thyl]-benzamide; side effect reduction
09/02/2004US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
09/02/2004US20040171617 treatment for disorders and diseases, such as chronic inflammation, tissue breakdown and cancer
09/02/2004US20040171616 preventing and treating thrombotic conditions, such as coronary artery disease, cerebrovascular disease, and other coagulation related disorders
09/02/2004US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents
09/02/2004US20040171075 Modulation of protein functionalities
09/02/2004US20040170634 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
09/02/2004CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/01/2004EP1452522A2 Novel compounds and compositions as protease inhibitors
09/01/2004EP1451167A1 Phenylalkynes
09/01/2004EP1450807A1 Method of treating depression with delta receptor agonist compounds
09/01/2004EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
09/01/2004EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
09/01/2004EP0827499B1 Process for producing 5,6-dihydro-1,3-oxazines
09/01/2004CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
09/01/2004CN1525964A Method for the production of biperidin
09/01/2004CN1525963A Method for producing biperiden i
09/01/2004CN1525959A Muller Klaus-helmut
09/01/2004CN1525958A Method for the production of biperiden ii
09/01/2004CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/01/2004CN1164573C Novel alpha-amino acid compound, its preparation process and medicinal composition containing same
08/2004
08/31/2004US6784323 Enantioselective transformation of α,β-unsaturated aldehydes using chiral organic catalysts
08/31/2004US6784295 Carried out in the presence of an inorganic base or organic nitrogen base and a palladium complex catalyst containing secondary monophosphines with aliphatic, branched or cyclic substituents as ligands
08/31/2004US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis
08/31/2004US6784183 Diphenylurea compounds
08/31/2004US6784173 Aromatic dicarboxylic acid derivatives
08/26/2004WO2004072020A1 Hydroxy-tetrahydro-naphthalenylurea derivatives
08/26/2004WO2004072018A1 Amine derivative
08/26/2004WO2004072015A1 Quaternary ammonium salts
08/26/2004WO2004071445A2 2-(aminomethyl)arylamide analgesics
08/26/2004WO2004058164A3 Asthma and allergic inflammation modulators
08/26/2004WO2004050610A3 Modulators of melanocortin receptor
08/26/2004WO2004039775A3 Il-8 receptor antagonists
08/26/2004WO2004018461A3 Antibacterial benzoic acid derivatives
08/26/2004WO2003087127A3 Antimicrobial compounds against staphylococci, mycobacteria, and other infectious agents
08/26/2004US20040167332 Boronic ester and acid compounds, synthesis and uses
08/26/2004US20040167303 Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators
08/26/2004US20040167216 Carbidopa prodrugs and derivatives, and compositions and uses thereof
08/26/2004US20040167191 Glutaminyl based DPIV inhibitors
08/26/2004US20040167183 Protein tyrosine phosphatase inhibitor; antidiabetic agents; hypotensive agents; cardiovascular disorders; inflammatory bowel disorders; antiulcer agents; wound healing agents; anticancer agents
08/26/2004US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
08/26/2004US20040167119 2-(aminomethyl) arylamide analgesics
08/26/2004US20040167118 Novel diarylalkene derivatives and novel diarylalkane derivatives
08/26/2004DE10125567B4 Carbonamid substituierte Phenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Carboxamide-substituted phenylurea derivatives, processes for their preparation and their use as medicaments
08/26/2004CA2515418A1 Hydroxy-tetrahydro-naphthalenylurea derivatives
08/25/2004EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis